BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
BIOREGENX, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
Bioregenx statistics
Financials through Mar 31, 2026, price as of Oct 16, 2026, median of Services-Computer Programming, Data Processing, Etc. companies for comparison
Valuation
| Measure | Bioregenx | Industry median |
|---|---|---|
| Market Cap | $3.89M | $283.76M |
| Enterprise Value | $4.02M | $296.20M |
| PS Ratio | 2.20 | 2.36 |
| P/OCF Ratio | 139.26 | 13.05 |
Enterprise value
| Measure | Bioregenx | Industry median |
|---|---|---|
| EV / Sales | 2.28 | 2.14 |
Income (trailing twelve months)
| Measure | Bioregenx | Industry median |
|---|---|---|
| Revenue | $1.77M | $289.17M |
| Gross Profit | $1.45M | $161.98M |
| Operating Income | -$1.10M | -$613.24K |
| Net Income | -$1.30M | -$301.07K |
| EBITDA | -$1.03M | -$156.35K |
| EPS (Diluted) | $0.00 | $0.00 |
Margins
| Measure | Bioregenx | Industry median |
|---|---|---|
| Gross Margin | 81.9% | 55.8% |
| Operating Margin | -62.4% | -1.81% |
| Profit Margin | -73.8% | -1.80% |
| EBITDA Margin | -58.1% | 0.60% |
Returns
| Measure | Bioregenx | Industry median |
|---|---|---|
| Return on Assets (ROA) | -318.0% | -2.82% |
Growth
| Measure | Bioregenx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -23.4% | 9.72% |
| Revenue Growth (3Y CAGR) | 253.0% | 7.66% |
Balance sheet
| Measure | Bioregenx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $45.81K | $43.42M |
| Total Debt | $182.56K | $204.00M |
| Net Cash (Debt) | -$136.76K | $2.04M |
| Net Cash Per Share | -$0.00 | $0.15 |
| Equity (Book Value) | -$4.53M | $52.29M |
| Book Value Per Share | -$0.00 | $1.93 |
| Tangible Book Value | -$4.53M | $3.06M |
| Working Capital | -$3.80M | $15.22M |
Financial position
| Measure | Bioregenx | Industry median |
|---|---|---|
| Current Ratio | 0.05 | 1.40 |
| Quick Ratio | 0.02 | 0.94 |
| Interest Coverage | -3.64 | -0.66 |
Cash flow (trailing twelve months)
| Measure | Bioregenx | Industry median |
|---|---|---|
| Operating Cash Flow | $27.91K | $8.52M |
Efficiency
| Measure | Bioregenx | Industry median |
|---|---|---|
| Asset Turnover | 4.31 | 0.64 |
| Inventory Turnover | 2.74 | 13.06 |
| Revenue Per Employee | $294.26K | $392.99K |
| Profits Per Employee | -$217.19K | -$4.47K |
| Employee Count | 6 | 531 |
Dividends and yields
| Measure | Bioregenx | Industry median |
|---|---|---|
| Earnings Yield | -33.5% | -0.92% |
Shares
| Measure | Bioregenx | Industry median |
|---|---|---|
| Shares Outstanding | 971,575,000 | 58,826,100 |
| Shares Change (YoY) | 3.15% | 2.21% |
| Shares Change (QoQ) | 0.26% | 0.06% |
| Float | 971,575,000 | 52,938,050 |
| Shares Held by Insiders | 0.00% | 13.2% |
Scores
| Measure | Bioregenx | Industry median |
|---|---|---|
| Altman Z-Score | -172.85 | 1.50 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Bioregenx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.